熱門資訊> 正文
Singular Genomics Systems报告第一季度结果
2024-05-15 04:46
- Singular Genomics Systems press release (NASDAQ:OMIC): Q1 Net loss was $25.0 million, or a loss of $0.34 per common share, compared to $23.6 million, or a loss of $0.33 per common share, in the first quarter of 2023.
- Revenue for the first quarter of 2024 was $0.4 million, consisting primarily of revenue recognized from one G4 instrument capital purchase and consumables sales during the quarter.
More on Singular Genomics Systems
- Singular Genomics Systems, Inc. (OMIC) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Singular Genomics Systems
- Historical earnings data for Singular Genomics Systems
- Financial information for Singular Genomics Systems
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
